Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Beneficial investors in Australian/New Zealand companies can have just five days to respond to shareholder meeting notifications, research shows 2023-03-13 06:00
Advanced machine learning company Trellis Data brings its leading-edge, explainable Artificial Intelligence technology to the United States market 2023-03-09 09:30
Seeing Machines, leading driver monitoring technology company, to present at 35th Annual Roth Conference 2023-03-06 21:00
US proteomics sector set for shake-up as new IonOpticks tech unveiled 2023-03-03 22:00
Inventia Life Science collaborates with MSD to develop 3D advanced cell models for neurodegenerative disease drug discovery 2023-02-16 06:00
US based COBRA diagnostic prostate cancer trial reaches recruitment target 2023-02-09 22:03
6clicks Adds GPT-3 to Accelerate Risk Management, Automate Compliance Mapping and Advance Accuracy 2023-02-08 22:06
Developers of PERC solar technology win 2023 Queen Elizabeth Prize for Engineering (QEPrize) 2023-02-08 03:45
Inmagene receives IND clearance for IMG-008, a long-acting IL-36R mAb 2023-02-06 18:00
Ground-breaking results in Phase 2 scleroderma study by Certa Therapeutics demonstrates improvement in more than 60% of patients 2023-02-06 13:01
Jackery Enters Australian Market to Power a Greener Future 2023-02-01 19:22
AI Coach creator Fingerprint for Success (F4S) raises AU$5 Million 2023-02-01 05:00
Appendix 4C - Q2 FY23 Quarterly Cash Flow Report 2023-01-31 20:25
Minviro completes successful capital raise of £2,100,000 and welcomes industry leading investors as new shareholders 2023-01-26 18:00
Whispir announces a partnership with a leading flexible and integrated payment and engagement platform, Everyware® 2023-01-18 21:53
SEA Electric Partners with MEVCO to Electrify 8,500 Hilux and Landcruiser Models for Mining Industry 2023-01-18 06:36
Really Simple Systems Announces Collaboration Project with Rareloop 2023-01-17 18:00
Denave unveils new visual identity 2023-01-12 15:30
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in the United States for the Treatment of Individuals with Multiple System Atrophy 2023-01-09 23:25
Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation) 2023-01-06 20:25
1 10 11 12 13 14 113